The invention provides novel substituted, bicyclic compounds which are useful as inhibitors of extra terminal domain BET protein function by binding to bromodomains. The pharmaceutical compositions comprising such compounds are for the prevention and treatment of diseases and conditions that are associated with bromodornain and extra terminal domain (BET) proteins.
申请公布号
AU2014284616(A2)
申请公布日期
2016.06.09
申请号
AU20140284616
申请日期
2014.06.20
申请人
ZENITH EPIGENETICS CORP.
发明人
QUINN, JOHN FREDERICK;WANG, RUIFANG;JIANG, MAY XIAOWU;MARTIN, GREGORY SCOTT;WAGNER, GREGORY STEVEN;YOUNG, PETER RONALD;DUFFY, BRYAN CORDELL;LIU, SHUANG
